Showing results (401-410 of 456) with videos related to
Sort By:
Pageof 46
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cellsE F Adams, B Huang, M Buchfelder, et al.Artificial Organs|June 1, 1986
Thromboembolic complications of the Jarvik-7 total artificial heart: case reportM M Levinson, R G Smith, R C Cork, et al.Blood Cells|January 1, 1980
Analysis and detection of B cell neoplasmsE P Frenkel, R G Smith, F S Ligler, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonistR J DeVita, D D Hollings, M T Goulet, et al.Journal of the National Medical Association|July 1, 1995
Conservative treatment of early-stage breast cancer in a medically indigent populationR G Smith, J C Landry, L L Hughes, et al.Journal of Medicinal Chemistry|April 1, 1994
A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429)W R Schoen, J M Pisano, K Prendergast, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinomaS H Park, W C Gray, I Hernandez, et al.American Journal of Clinical Oncology|August 1, 1994
Conservative treatment of early-stage breast cancer. The Emory experienceR G Smith, J C Landry, W C Wood, et al.The Journal of Endocrinology|February 1, 1997
Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beaglesG J Hickey, T M Jacks, K D Schleim, et al.Radiology|August 1, 1993
Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II studyJ C Landry, M J Koretz, W C Wood, et al.Pageof 46